financetom
Business
financetom
/
Business
/
Greenwich LifeSciences Initiates Clinical Trial Sites for Potential Breast Cancer Recurrence Therapy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Greenwich LifeSciences Initiates Clinical Trial Sites for Potential Breast Cancer Recurrence Therapy
Mar 19, 2026 3:52 AM

06:38 AM EDT, 03/19/2026 (MT Newswires) -- Greenwich LifeSciences ( GLSI ) said Thursday that it has initiated new clinical sites in the US for a phase 3 trial of GLS-100, a fast-track-designated immunotherapy to prevent breast cancer recurrences.

The clinical trial has recently been activated at City of Hope network sites in southern California, Arizona, Atlanta, and Illinois.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Futu Holdings' Q2 Earnings, Revenue Increase
Futu Holdings' Q2 Earnings, Revenue Increase
Aug 20, 2024
05:24 AM EDT, 08/20/2024 (MT Newswires) -- Futu Holdings ( FUTU ) reported Q2 earnings Tuesday of 8.66 Hong Kong dollars ($1.11) per diluted American depositary share, up from HK$7.99 per ADS a year earlier. Two analysts polled by Capital IQ expected HK$7.69 per ADS. Revenue for the quarter ended June 30 was HK$3.13 billion, up from HK$2.48 billion a...
Why Alibaba, Nio, Baidu And Other Chinese Stocks Are Trading Lower In Premarket Today
Why Alibaba, Nio, Baidu And Other Chinese Stocks Are Trading Lower In Premarket Today
Aug 20, 2024
In a recent development, major Chinese stocks including Alibaba Group Holdings , NIO Inc. ( NIO ) , and Li Auto ( LI ) have seen a decline in premarket trading on Tuesday. What Happened: In Tuesday’s premarket, Alibaba’s shares were trading 1.78% lower, while its rival JD.Com Inc. ( JD ) was trading 2.30% lower. EV makers Li Auto...
Fertilizer Canada says rail stoppage to cost industry up to $63 million a day
Fertilizer Canada says rail stoppage to cost industry up to $63 million a day
Aug 20, 2024
By Mrinalika Roy (Reuters) -Fertilizer Canada warned on Tuesday disruptions impacting all rail services across the country will cost the fertilizer industry an estimated $55 million to $63 million per day in lost sales revenue, not including logistical and operational costs. Canada is the largest producer and exporter of potash - the key ingredient in fertilizers - and 75% of...
Update: Fabrinet Fiscal Q4 Non-GAAP EPS, Sales Jump; Repurchases Expanded; Shares Surge Premarket
Update: Fabrinet Fiscal Q4 Non-GAAP EPS, Sales Jump; Repurchases Expanded; Shares Surge Premarket
Aug 20, 2024
05:36 AM EDT, 08/20/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Fabrinet ( FN ) shares were up over 9% in premarket activity Tuesday after the company overnight reported higher fiscal Q4 earnings and sales, beating expectations, and unveiled an expanded stock buyback program. The company reported fiscal Q4 non-GAAP earnings late...
Copyright 2023-2026 - www.financetom.com All Rights Reserved